1887

Abstract

SUMMARY

Mouse L cell lines have been developed which constitutively express glycoproteins B (gB) and D (gD) of herpes simplex virus type 1. When used to study the immune response of mice to the viral glycoproteins, it was found that both gB and gD induce a delayed type hypersensitivity response and both also induce an antibody response, but only the cell line expressing gD could stimulate the production of neutralizing antibody. Virus-specific cytotoxic T lymphocytes (CTLs) recognized gB expressed by the cell line and this line could also induce CTLs in mice. Recognition of gD by major histocompatibility complex class I restricted CTLs was never seen. Vaccination of mice with the cell lines provided protection from viral challenge and inhibited the establishment of a latent infection, although gD proved to be the better protective immunogen.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-4-1103
1987-04-01
2021-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/4/JV0680041103.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-4-1103&mimeType=html&fmt=ahah

References

  1. Balachandran N., Bacchetti S., Rawls W. E. 1982; Protection against lethal challenge of Balb/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infection and Immunity 37:1132–1137
    [Google Scholar]
  2. Berman P. W., Gregory T., Crase D., Lasky L. A. 1985; Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227:1490–1492
    [Google Scholar]
  3. Bonner W. M., Laskey R. A. 1974; A film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels. European Journal of Biochemistry 46:83–88
    [Google Scholar]
  4. Buckmaster E. A., Gompels U., Minson A. 1984; Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 × 103molecular weight. Virology 139:408–413
    [Google Scholar]
  5. Bzik D. J., Fox B. A., Deluca N. A., Person S. 1984; Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology 133:301–314
    [Google Scholar]
  6. Carter V. C., Schaffner P. A., Tevethia S. S. 1981; The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. Journal of Immunology 126:1655–1660
    [Google Scholar]
  7. Chan W. L., Lukig M. L., Liew F. Y. 1985; Helper T cells induced by an immunopurified herpes simplex virus type 1 (HSV-1) 115 kilodalton glycoprotein (gB) protect mice against HSV-1 infection. Journal of Experimental Medicine 162:1304–1318
    [Google Scholar]
  8. Colombatti A., Hilgers J. 1979; A radioimmunoassay for virus antibody using binding of125I-labelled Protein A. Journal of General Virology 43:395–401
    [Google Scholar]
  9. Cremer K. J., Mackett M., Wohlenberg C., Notkins A. L., Moss B. 1985; Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737–740
    [Google Scholar]
  10. Darby G., Bastow K. F., Minson A. C. 1981; Transfections with HSV DNA fragments and DNA from HSV transformed cells. In Developments in Molecular Virology 1 Herpesvirus DNA pp 223–253 Becker Y. Edited by The Hague, Boston & London: Martinus Nijhoff Publishers;
    [Google Scholar]
  11. Eisenberg R. J., Ponce De Leon M., Pereira L., Long D., Cohen G. H. 1982; Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. Journal of Virology 41:1099–1104
    [Google Scholar]
  12. Eisenberg R. J., Cerini C. P., Heilman C. J., Joseph A. D., Dietzschold B., Golub E., Long D., Poncedeleon M., Cohen G. H. 1985; Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. Journal of Virology 56:1014–1017
    [Google Scholar]
  13. Fiers W., Contreras J., Haegeman G., Rogiers R., Van De Voorde A., Van Heuverswyn H., Van Herreweghe J., Volckaert G., Ysebaert M. 1978; Complete nucleotide sequence of SV40 DNA. Nature; London: 273113–120
    [Google Scholar]
  14. Frame M. C., Marsden H. S., Mcgeoch D. J. 1986; Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. Journal of General Virology 67:745–751
    [Google Scholar]
  15. Glorioso J., Kees U., Kumel G., Kirchner H., Krammer P. H. 1985; Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1 specific memory cytotoxic T lymphocytes. Journal of Immunology 135:575–582
    [Google Scholar]
  16. Hill T. J., Field H. J., Blyth W. A. 1975; Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28:341–353
    [Google Scholar]
  17. Johnson D. C., Smiley J. R. 1985; Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells. Journal of Virology 54:682–689
    [Google Scholar]
  18. Kumel G., Kaerner H. C., Levine M., Schroder C. H., Glorioso J. C. 1985; . Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity Journal of Virology 56:930–937
    [Google Scholar]
  19. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 221680–685
    [Google Scholar]
  20. Lawman M. J. P., Courtney R. J., Eberle R., Schaffer P. A., O’Hara M. K., Rouse B. T. 1980; Cell mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infection and Immunity 30:451–161
    [Google Scholar]
  21. Long D., Madara T. J., Poncedeleon M., Cohen G. H., Montgomery P. C., Eisenberg R. J. 1984; Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infection and Immunity 43:761–764
    [Google Scholar]
  22. Minson A. C., Wildy P., Buchan A., Darby G. 1978; Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA. Cell 13:581–587
    [Google Scholar]
  23. Nash A. A., Field H. J., Quartey-Papafio R. 1980a; Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. Journal of General Virology 48:351–357
    [Google Scholar]
  24. Nash A. A., Quartey-Papafio R., Wildy P. 1980b; Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. Journal of General Virology 49:309–317
    [Google Scholar]
  25. Nash A. A., Leung K-N., Wildy P. 1985; The T-cell-mediated immune response of mice to herpes simplex virus. In The Herpesviruses 4 pp 87–102 Roizman B., Lopez C. Edited by New York: Plenum Press;
    [Google Scholar]
  26. Nash A. A., Jayasuriya A., Phelan J., Cobbold S. P., Waldmann H., Prospero T. 1987; Different roles for L3T4+and Lyt 2+T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. Journal of General Virology 68:825–833
    [Google Scholar]
  27. Norrild B. 1985; Humoral response to herpes simplex virus infections. In The Herpesviruses 4 pp 69–86 Roizman B., Lopez C. Edited by New York: Plenum Press;
    [Google Scholar]
  28. Paoletti E., Lipinskas B. R., Samsonoff C., Mercer S., Panicali D. 1984; Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences U.S.A.: 81193–197
    [Google Scholar]
  29. Pfizenmaier K., Jung H., Starzinski-Powitz A., Rollinghoff M., Wagner H. 1977; The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. Journal of Immunology 119:939–944
    [Google Scholar]
  30. Rector J. T., Lausch R. N., Oakes J. E. 1982; Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infection and Immunity 38:168–174
    [Google Scholar]
  31. Reddehase M. J., Koszinowski U. H. 1984; Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature; London: 312369–371
    [Google Scholar]
  32. Richman D. D., Buckmaster A., Bell S., Hodgman C., Minson A. C. 1986; Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. Journal of Virology 57:647–655
    [Google Scholar]
  33. Schrier R. D., Pizer L. I., Moorhead J. W. 1983; Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. Journal of Immunology 130:1413–1418
    [Google Scholar]
  34. Simmons A., Nash A. A. 1984; Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. Journal of Virology 52:816–821
    [Google Scholar]
  35. Simmons A., Nash A. A. 1985; Role of antibody in primary and recurrent herpes simplex virus infection. Journal of Virology 53:944–948
    [Google Scholar]
  36. Simmons A., Nash A. A. 1987; The effect of B cell suppression on primary infection and re-infection of mice with herpes simplex virus. Journal of Infectious Diseases in press
    [Google Scholar]
  37. Spear P. G. 1985; Glycoproteins specified by herpes simplex virus. In The Herpesviruses 3 pp 315–356 Roizman B. Edited by New York: Plenum Press;
    [Google Scholar]
  38. Townsend A. R. M., McMichael A. J., Carter N. P., Huddleston J. A., Brownlee G. G. 1984; Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39:13–25
    [Google Scholar]
  39. Wagner M. J., Sharp J. A., Summers W. C. 1981; Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proceedings of the National Academy of Sciences U.S.A.: 781441–1445
    [Google Scholar]
  40. Watson R. J., Weis J. H., Salstrom J. S., Enquist L. W. 1982; HSV-1 glycoprotein D gene: nucleotide sequence and expression inE. coli . Science 218:381–384
    [Google Scholar]
  41. Yewdell J. W., Bennink J. R., Mackett M., Lefrancois L., Lyles D. S., Moss B. 1986; Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. Journal of Experimental Medicine 163:1529–1538
    [Google Scholar]
  42. Zarling J. M., Moran P. A., Burke R. L., Pachl C., Berman P. W., Lasky L. A. 1986a; Human Cytotoxic T Cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD. Journal of Immunology 136:4669–4673
    [Google Scholar]
  43. Zarling J. M., Moran P. A., Lasky L. A., Moss B. 1986b; Herpes simplex virus (HSV)-specific human T-cell clones recognise HS V glycoprotein D expressed by a recombinant vaccinia virus. Journal of Virology 59:506–509
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-4-1103
Loading
/content/journal/jgv/10.1099/0022-1317-68-4-1103
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error